Health
Singapore develops potential antibody treatment for yellow fever – BSA bureau
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
Researchers from Antimicrobial Resistance (AMR), an interdisciplinary group at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed TY014, a potential antibody treatment for yellow fever. SMART AMR collaborated with researchers from Massachusetts Institute of Technology (MIT), and local institutions such as the Singapore Ge…
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News14 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General24 hours agoDe Minaur to face Djokovic at Wimbledon, as Kasatkina bows out in straight sets
-
General17 hours agoBack-to-back rate cuts tipped when Reserve Bank meets